Acute lymphoblastic leukemia and Down syndrome
Open Access
Abstract
BACKGROUND.: The presenting features and treatment outcome of 120 patients with Down syndrome (DS) and childhood acute lymphoblastic leukemia (ALL) were compared with 6237 non‐DS patients treated in the same years.METHODS.: We reviewed the database of 6 consecutive Italian Association of Pediatric Hematology and Oncology (AIEOP)‐ALL trials conducted between 1982 and 2004. Features of DS patients were compared with those of non‐DS patients.RESULTS.: The 120 DS patients (1.9%) were more often girls (P = .027), aged ≥10 years (P = .014), and high risk according to National Cancer Institute (NCI) criteria (P = .045). The distribution of white blood cell count did not differ (P = .32). DS patients belonged less frequently to the current high‐risk group (P = .017). In all but 1 case they demonstrated B‐cell precursor (BCP) immunophenotype (P≤.001). TEL/AML1 molecular fusion transcript was found in only 1 of 44 (2.2%) tested patients. Induction death occurred more often in DS patients (4.2%, P = .009), but not failure to achieve remission. Leukemia relapse occurred in 31.6% of DS patients (vs 23.5%; P = .003), usually in the marrow. Remission death was more frequent in DS patients (4.2%, P = .03). Ten‐year event‐free survival and survival were significantly worse compared with non‐DS patients (P < 0.001). DS patients diagnosed since 1995 had a better outcome (P = .06) than those diagnosed in previous years, but still had worse outcomes than non‐DS patients (P = .04). Event‐free survival of DS patients at NCI standard risk was lower than that of non‐DS patients (P = .006).CONCLUSIONS.: Presenting features of childhood ALL in DS differ from those in non‐DS patients. They are almost invariably characterized by BCP phenotype, and are often TEL/AML1 negative. Treatment results, although not as good as for non‐DS patients, improved progressively, with modern therapy and support allowing 75% to survive. Cancer 2008. © 2008 American Cancer Society.Keywords
This publication has 24 references indexed in Scilit:
- Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG studyBlood, 2008
- Trisomy of chromosome 21 in leukemogenesisBlood Cells, Molecules, and Diseases, 2007
- Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01Blood, 2006
- Clinical and bilogical characteristics of acute lymphocytic leukemia in children with Down syndromeAmerican Journal of Medical Genetics, 2005
- Acute leukaemia in children with Down syndrome: a population‐based Nordic studyBritish Journal of Haematology, 2005
- Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Acute Lymphoblastic Leukemia Studies, 1982–1995Leukemia, 2000
- Patterns of care and survival for children with acute lymphoblastic leukaemia diagnosed between 1980 and 1994Archives of Disease in Childhood, 1999
- Down’s syndrome in childhood acute lymphoblastic leukemia: clinical characteristics and treatment outcome in four consecutive BFM trialsLeukemia, 1998
- Prognosis of Down's syndrome with acute leukaemia.Archives of Disease in Childhood, 1990
- Down syndrome and acute leukemia in children: A 10-year retrospective survey from Childrens Cancer Study GroupThe Journal of Pediatrics, 1984